NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OTG Acquisition Corp. I (Nasdaq: OTGAU) (the “Company”), a special purpose acquisition company, today announced that, commencing on or about November 3, 2025, holders of the units sold in the Company’s initial public offering completed on September 15, 2025 (the “offering”), may elect to separately trade the ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The ...

DUBLIN, IRELAND, Oct. 29, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on December 18, 2025, to shareholders of record at the close of business on November 18, 2025. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and services that su ...

CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) announces that it submitted a Proposal (the “Proposal”) to the Board of Directors of GeoPark (NYSE: GPRK) to acquire all outstanding common shares of GeoPark for US$9.00 per share in cash. Following a lack of constructive engagement with, and rejection of the Proposal by the Board of Directors of GeoPark (the “GeoPark Board”), Parex has also acquired an 11.8% ownership position in GeoPark. The Prop ...

CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Canoe Financial LP (“Canoe Financial”) is pleased to announce that two of its alternative funds were recognized with a total of six awards for absolute and risk-adjusted returns at the Alternative IQ 2025 Canadian Hedge Fund Awards in Toronto. Canoe Energy Alpha Fund LP • 1st place Overall Best 2025 Canadian Hedge Fund (based on 10-year return and Sharpe Ratio)Equity Focused Category• 1st place 5-year return• 1st place 10-year return• 2nd place 5-year Shar ...

Southfield, MI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Net Income per Diluted Share of $0.07 for the Quarter, inclusive of Income from Discontinued Operations Core FFO per Share of $2.28 for the Quarter North America Same Property NOI for MH and RV Increased by 5.4% for the Quarter on a Year-over-Year Basis North America Same Property Adjusted Blended Occupancy for MH and RV of 99.2% Represents a 130 Basis Point Year-over-Year Increase Completed Sale of Remaining Safe Harbor Marinas Delayed Con ...

DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- National Bank Holdings Corporation (NYSE: NBHC) announced today that its Board of Directors declared a quarterly cash dividend to shareholders. The cash dividend will increase 3.3% from thirty cents ($0.30) to thirty-one cents ($0.31) per share of NBHC common stock. The dividend will be payable on December 15, 2025 to shareholders of record at the close of business on November 28, 2025. “We are pleased to announce another increase to our quarterly dividend, reinforc ...

Core Insights - The pivotal Phase 3 clinical trial for Trappsol Cyclo™ is ongoing, with positive recommendations from the Data Monitoring Committee [1][2] - The company successfully closed a $25 million rights offering, enhancing its financial position to support the Trappsol Cyclo™ program and other opportunities [2] - Rafael Holdings reported a net loss of $12.1 million for Q4 FY 2025, an increase from a net loss of $4.5 million in the same period last year, primarily due to the consolidation of Cyclo Therapeutics' expenses [4][5] Financial Performance - As of July 31, 2025, the company had cash and cash equivalents of $52.8 million, following the $25 million rights offering closed in June 2025 [3] - For the three months ended July 31, 2025, research and development expenses rose to $7.5 million from $1.5 million year-over-year, reflecting increased spending at Cyclo Therapeutics [5] - General and administrative expenses for the same period were $5.5 million, up from $2.3 million in the prior year, also due to the inclusion of Cyclo's expenses [6] Yearly Overview - For the full fiscal year 2025, Rafael Holdings recorded a net loss of $30.5 million, an improvement from a net loss of $34.4 million in the previous year [7] - Research and development expenses for the full year were $12.8 million, compared to $4.2 million in the prior year, driven by the acquisition of Cyclo Therapeutics [8] - General and administrative expenses for the full year increased to $13.8 million from $8.9 million, attributed to the consolidation of Cyclo and other entities [9][10] Company Background - Rafael Holdings, Inc. is a biotechnology company focused on developing pharmaceuticals, with its lead candidate Trappsol® Cyclo™ aimed at treating Niemann-Pick Disease Type C1 [11]

EXTON, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OMEGA FLEX, INC. (OFLX) Nine Months Ended September 30, Three Months Ended September 30, 2025 2024<td style="max-width:1%; width:1%; min-width:1%;; ...

Elgin, IL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) (the “Company”) today announced that its Board of Directors (the “Board”) declared a special cash dividend (the “Special Dividend”) of $1.00 per share on all issued and outstanding shares of Common Stock of the Company and $1.00 per share on all issued and outstanding shares of Class A Common Stock of the Company. The Special Dividend will return approximately $11.7 million to Company stockholders. The Special Dividen ...

INDIANAPOLIS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE: KRG), a premier owner and operator of high-quality, open-air grocery-anchored centers and vibrant mixed-use assets, reported today its operating results for the third quarter ended September 30, 2025. For the quarters ended September 30, 2025 and 2024, net loss attributable to common shareholders was $16.2 million, or $0.07 per diluted share, compared to net income of $16.7 million, or $0.08 per diluted share, respectively. For the nin ...